Subclinical atherosclerosis in young beta-thalassemia major patients. - sprookjes - yvandenbroek - TriplyDB

Subclinical atherosclerosis in young beta-thalassemia major patients.

Subclinical atherosclerosis in young beta-thalassemia major patients.

http://www.wikidata.org/entity/Q43230817

about

Atherogenesis and iron: from epidemiology to cellular level.Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.The Role of the Carotid Doppler Examination in the Evaluation of Atherosclerotic Changes in β-Thalassemia Patients Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.Vascular dysfunction in patients with young β-thalassemia: relation to cardiovascular complications and subclinical atherosclerosis.Carotid Doppler ultrasonography as a screening tool of early atherosclerotic changes in children and young adults with β-thalassemia major.Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.No Association of Genetic Markers with Carotid Intimal Medial Thickness in β-Thalassemia Major Patients.Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness.Joint diabetes thalassaemia clinic: an effective new model of care.

P2860

Q33595279-2A75A396-F446-4B95-BC48-675A4F1B2A74 Q34042394-DC7907E7-B5A0-48B0-8872-75F732A5041C Q35130013-5F4CFFD3-B9A8-4BDB-BD5B-1A98213E52F4 Q36303189-C574F74F-1135-4B51-A71D-6433FF69000F Q36710918-CBBC4FBF-62E9-4A99-8140-B9B8CAAA340B Q46168149-CF572304-4955-45A7-8EC7-C01A54BC43AE Q46227472-AB5EE22E-E7FF-4F2F-B55F-165C6F7059D8 Q46590378-4C572B09-0463-4996-A569-72FC5784C492 Q47796030-C78676E6-6987-4F82-A8D1-522ED5CB03AD Q50021871-3366D675-97DE-4D22-A4D7-7A9E2B71F69E Q50493543-E7FFB48C-1AFC-4E30-B62C-8514EAAA328C Q54421844-3220293B-C4FA-464B-89FD-E2FC85A7C799

P2860

Subclinical atherosclerosis in young beta-thalassemia major patients.

http://www.wikidata.org/entity/Q43230817

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Subclinical atherosclerosis in young beta-thalassemia major patients.

@en

Subclinical atherosclerosis in young beta-thalassemia major patients.

@nl

type

label

Subclinical atherosclerosis in young beta-thalassemia major patients.

@en

Subclinical atherosclerosis in young beta-thalassemia major patients.

@nl

prefLabel

Subclinical atherosclerosis in young beta-thalassemia major patients.

@en

Subclinical atherosclerosis in young beta-thalassemia major patients.

@nl

P1433

Q43230817-411E90A0-9031-45CB-916C-2B2D98FC79BA

P1476

Q43230817-EB036209-2273-4DB6-AE4A-D23626DA5908

P2093

Q43230817-087523F5-F057-4F26-AC60-23DDDF74DDE5

Q43230817-A540DC41-BB47-4DCB-8D2C-1E69E6CEBBB7

Q43230817-AAEAB6EC-6B8A-4096-8CA9-2629A0C6EECC

P2860

Q43230817-037C6BAB-AECC-473B-948B-C7C34DBD1A3F

Q43230817-08738B46-1555-4846-B967-E78FDD578D05

Q43230817-18C09FA2-85EA-4FCF-AEB3-C81C0213DDA4

Q43230817-1A3ABDB8-194F-4804-9D93-9D557B222031

Q43230817-2F62FF94-EF6A-4A67-A02A-9B74B8E834C5

Q43230817-3420F4D1-EB80-4BCA-8EAE-D782B26F7BC7

Q43230817-579E6212-4CC4-4CD1-BC1E-8E0A4353FB9D

Q43230817-6C84D683-D103-41FA-9DF2-E16541E262B0

Q43230817-7725B8B7-C6ED-4A5E-9A8D-6C2A23644B82

Q43230817-7BD41021-81CF-419C-BA49-2AD141C109CF

P304

Q43230817-A9ED206B-E335-4BEA-B0B9-427D69C042D5

P31

Q43230817-425E2746-D2F5-4FB7-A343-F1616DD433BA

P356

Q43230817-81A679F1-F9E7-4897-8286-4D3B8800B735

P433

Q43230817-8976140A-3208-440E-A5A0-BC77CA8DFB6B

P478

Q43230817-0AAB2565-45B9-400A-B2CA-3EF6021AEDA8

P50

Q43230817-7F99491C-FE39-4A6F-AF29-8A31BDFA196B

P577

Q43230817-A2A25F72-21CF-4CAA-92FC-2AD18A9C7A49

P698

Q43230817-8ED561D2-4794-4567-B6BE-598B231C4480

P921

Q43230817-83BC5B63-94C1-40F8-8A18-F37F192C983F

P356

03630260903343616

P1433

P1476

Subclinical atherosclerosis in young beta-thalassemia major patients

@en

P2093

Amira A M Adly

http://www.w3.org/2001/XMLSchema#string

Mohamed G A El Maaty

http://www.w3.org/2001/XMLSchema#string

Shatha A G Amin

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Lipoprotein(a) in cirrhosis.

Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children.

Type 1 diabetes and coronary artery disease.

Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?

The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies.

Identification of novel Asian Indian and Japanese mutations causing beta-thalassaemia in the Egyptian population.

Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control.

Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major.

P304

463-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03630260903343616

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

AZZA A.G. TANTAWY

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19958191

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis